Switch from antibiotic eye drops to instillation of mother's milk drops as a treatment of infant epiphora

J Trop Pediatr. 2007 Feb;53(1):68-9. doi: 10.1093/tropej/fml063. Epub 2006 Dec 6.


In a paediatric practice, the management of patients with signs and symptoms of congenital nasolacrimal duct obstruction (CNLO) was switched from topical antibiotic to topical mother's milk (MM) -based regimens. The conservative management of this condition includes frequent cleansing of the lids, digital lacrimal sac massage, and application of topical antibiotic drops when there is a mucopurulent discharge. The method for managing CNLO has evolved in our office of paediatrics during the past 7 years. This change was initiated by some mothers who have applied traditional therapy: MM eye drops. This evolution has been accompanied by a number of articles from the mid 1990s into the 2000s on safety of MM eye drops in case of neonatal conjunctivitis, and on the anti-inflammatory characteristics and antibacterial activity of topical MM.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Infective Agents / administration & dosage*
  • Female
  • Humans
  • Infant, Newborn
  • Lacrimal Apparatus Diseases / drug therapy*
  • Male
  • Milk, Human*
  • Ophthalmic Solutions / administration & dosage
  • Prognosis
  • Statistics, Nonparametric
  • Treatment Outcome


  • Anti-Infective Agents
  • Ophthalmic Solutions